vs

Side-by-side financial comparison of Progyny, Inc. (PGNY) and ROYAL GOLD INC (RGLD). Click either name above to swap in a different company.

ROYAL GOLD INC is the larger business by last-quarter revenue ($375.3M vs $318.4M, roughly 1.2× Progyny, Inc.). ROYAL GOLD INC runs the higher net margin — 24.9% vs 3.9%, a 21.0% gap on every dollar of revenue. On growth, ROYAL GOLD INC posted the faster year-over-year revenue change (85.3% vs 6.7%). Over the past eight quarters, ROYAL GOLD INC's revenue compounded faster (58.8% CAGR vs 7.0%).

Progyny, Inc. is a leading fertility and family building benefits provider operating primarily in the United States. It partners with employers to offer benefits including in vitro fertilization, fertility preservation, adoption assistance, and surrogacy support, serving millions of members across diverse industry segments.

Royal Gold Inc. is a leading precious metals streaming and royalty firm that acquires and manages a diversified portfolio of streaming interests, royalties, and equity interests tied to mining projects. Its assets cover gold, silver, and copper production across North America, South America, Africa, and Australia, operating with a low-risk model that avoids direct mining operations.

PGNY vs RGLD — Head-to-Head

Bigger by revenue
RGLD
RGLD
1.2× larger
RGLD
$375.3M
$318.4M
PGNY
Growing faster (revenue YoY)
RGLD
RGLD
+78.6% gap
RGLD
85.3%
6.7%
PGNY
Higher net margin
RGLD
RGLD
21.0% more per $
RGLD
24.9%
3.9%
PGNY
Faster 2-yr revenue CAGR
RGLD
RGLD
Annualised
RGLD
58.8%
7.0%
PGNY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PGNY
PGNY
RGLD
RGLD
Revenue
$318.4M
$375.3M
Net Profit
$12.5M
$93.6M
Gross Margin
24.1%
64.6%
Operating Margin
4.8%
56.2%
Net Margin
3.9%
24.9%
Revenue YoY
6.7%
85.3%
Net Profit YoY
18.5%
-12.8%
EPS (diluted)
$0.14
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PGNY
PGNY
RGLD
RGLD
Q4 25
$318.4M
$375.3M
Q3 25
$313.3M
$252.1M
Q2 25
$332.9M
$209.6M
Q1 25
$324.0M
$193.4M
Q4 24
$298.4M
$202.6M
Q3 24
$286.6M
$193.8M
Q2 24
$304.1M
$174.1M
Q1 24
$278.1M
$148.9M
Net Profit
PGNY
PGNY
RGLD
RGLD
Q4 25
$12.5M
$93.6M
Q3 25
$13.9M
$126.8M
Q2 25
$17.1M
$132.3M
Q1 25
$15.1M
$113.5M
Q4 24
$10.5M
$107.4M
Q3 24
$10.4M
$96.2M
Q2 24
$16.5M
$81.2M
Q1 24
$16.9M
$47.2M
Gross Margin
PGNY
PGNY
RGLD
RGLD
Q4 25
24.1%
64.6%
Q3 25
23.2%
73.6%
Q2 25
23.7%
72.6%
Q1 25
23.4%
69.4%
Q4 24
21.3%
70.3%
Q3 24
20.7%
66.6%
Q2 24
22.5%
64.7%
Q1 24
22.4%
58.4%
Operating Margin
PGNY
PGNY
RGLD
RGLD
Q4 25
4.8%
56.2%
Q3 25
6.9%
64.4%
Q2 25
7.3%
67.7%
Q1 25
7.5%
63.6%
Q4 24
5.3%
65.9%
Q3 24
4.3%
61.3%
Q2 24
6.8%
58.6%
Q1 24
6.7%
50.7%
Net Margin
PGNY
PGNY
RGLD
RGLD
Q4 25
3.9%
24.9%
Q3 25
4.4%
50.3%
Q2 25
5.1%
63.1%
Q1 25
4.6%
58.7%
Q4 24
3.5%
53.0%
Q3 24
3.6%
49.7%
Q2 24
5.4%
46.6%
Q1 24
6.1%
31.7%
EPS (diluted)
PGNY
PGNY
RGLD
RGLD
Q4 25
$0.14
$1.04
Q3 25
$0.15
$1.92
Q2 25
$0.19
$2.01
Q1 25
$0.17
$1.72
Q4 24
$0.12
$1.63
Q3 24
$0.11
$1.46
Q2 24
$0.17
$1.23
Q1 24
$0.17
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PGNY
PGNY
RGLD
RGLD
Cash + ST InvestmentsLiquidity on hand
$112.2M
$233.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$516.0M
$7.2B
Total Assets
$742.4M
$9.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PGNY
PGNY
RGLD
RGLD
Q4 25
$112.2M
$233.7M
Q3 25
$134.0M
$172.8M
Q2 25
$132.5M
$248.2M
Q1 25
$109.2M
$240.8M
Q4 24
$162.3M
$195.5M
Q3 24
$91.5M
$127.9M
Q2 24
$95.0M
$74.2M
Q1 24
$115.0M
$137.9M
Total Debt
PGNY
PGNY
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$50.0M
Q1 24
Stockholders' Equity
PGNY
PGNY
RGLD
RGLD
Q4 25
$516.0M
$7.2B
Q3 25
$560.0M
$3.4B
Q2 25
$515.0M
$3.3B
Q1 25
$467.2M
$3.2B
Q4 24
$422.1M
$3.1B
Q3 24
$434.9M
$3.0B
Q2 24
$456.2M
$3.0B
Q1 24
$571.6M
$2.9B
Total Assets
PGNY
PGNY
RGLD
RGLD
Q4 25
$742.4M
$9.5B
Q3 25
$795.2M
$4.5B
Q2 25
$761.0M
$3.6B
Q1 25
$730.3M
$3.5B
Q4 24
$607.1M
$3.4B
Q3 24
$660.0M
$3.3B
Q2 24
$698.6M
$3.3B
Q1 24
$794.3M
$3.3B
Debt / Equity
PGNY
PGNY
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PGNY
PGNY
RGLD
RGLD
Operating Cash FlowLast quarter
$54.2M
$241.7M
Free Cash FlowOCF − Capex
$48.6M
FCF MarginFCF / Revenue
15.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.34×
2.58×
TTM Free Cash FlowTrailing 4 quarters
$191.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PGNY
PGNY
RGLD
RGLD
Q4 25
$54.2M
$241.7M
Q3 25
$50.7M
$174.0M
Q2 25
$55.5M
$152.8M
Q1 25
$49.8M
$136.4M
Q4 24
$52.2M
$141.1M
Q3 24
$44.5M
$136.7M
Q2 24
$56.7M
$113.5M
Q1 24
$25.7M
$138.3M
Free Cash Flow
PGNY
PGNY
RGLD
RGLD
Q4 25
$48.6M
Q3 25
$46.0M
Q2 25
$50.2M
Q1 25
$47.0M
Q4 24
$50.3M
Q3 24
$42.7M
Q2 24
$55.8M
Q1 24
$24.9M
FCF Margin
PGNY
PGNY
RGLD
RGLD
Q4 25
15.3%
Q3 25
14.7%
Q2 25
15.1%
Q1 25
14.5%
Q4 24
16.8%
Q3 24
14.9%
Q2 24
18.4%
Q1 24
8.9%
Capex Intensity
PGNY
PGNY
RGLD
RGLD
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.6%
Q1 25
0.9%
Q4 24
0.6%
Q3 24
0.6%
Q2 24
0.3%
Q1 24
0.3%
Cash Conversion
PGNY
PGNY
RGLD
RGLD
Q4 25
4.34×
2.58×
Q3 25
3.65×
1.37×
Q2 25
3.24×
1.15×
Q1 25
3.31×
1.20×
Q4 24
4.95×
1.31×
Q3 24
4.27×
1.42×
Q2 24
3.44×
1.40×
Q1 24
1.52×
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PGNY
PGNY

Fertility Benefit Services$208.6M66%
Pharmacy Benefit Services$109.8M34%

RGLD
RGLD

Gold$216.9M58%
Pueblo Viejo$47.3M13%
Andacollo$32.6M9%
Silver$32.1M9%
Other$27.2M7%
Copper$13.7M4%
Cortez Legacy Zone$5.4M1%

Related Comparisons